Kishiwada City Hospital

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Lung cancer3 trials
• Asthma2 trials
• COPD1 trial

Phase

• Phase 34 trials
• Phase 22 trials

Status

• Active, not recruiting3 trials
• Completed3 trials

Lead sponsor

• Eli Lilly and Company1 trial
• Hoffmann-La Roche1 trial
• Incyte Corporation1 trial
• Janssen Research & Development, LLC1 trial
• PharmaMar1 trial
• and 1 more

Running trials

• Active, not recruiting

  A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma

  NCT05851443· Phase 2· Incyte Corporation· Source

• Active, not recruiting

  A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Characterized by Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions

  NCT04538664· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  A Study of Ramucirumab (LY3009806) in Combination With Erlotinib in Previously Untreated Participants With EGFR Mutation-Positive Metastatic NSCLC (RELAY)

  NCT02411448· Phase 3· Eli Lilly and Company· Source

Closed trials

• Completed

  A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)

  NCT06196879· Phase 2· Upstream Bio Inc.· Source

• Completed

  A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease

  NCT05595642· Phase 3· Hoffmann-La Roche· Source

• Completed

  Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON)

  NCT05153239· Phase 3· PharmaMar· Source